The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases ...

Whether or not you choose to cover weight loss drugs, offering holistic support can make a meaningful difference in employee ...

A large majority of older Americans feel that health insurance—including Medicare—should cover anti-obesity medications, ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently recommended six months—can more than double weight loss for patients who struggle ...

are denied coverage for anti-obesity medications, even though these treatments have been shown to reduce weight, improve overall health, prevent or manage obesity-related conditions, and for some ...

Eli Lilly has launched Mounjaro, a first-of-its-kind drug for obesity and type 2 diabetes, in India. This medication, approved by CDSCO, helps with we ...